NCT06820255 2025-02-11
SELECTIO-UC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Recruiting
Clinical Trials
14 trialsNCT06818773 2025-02-10
Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
Eastern Hepatobiliary Surgery Hospital
Phase 4 Not yet recruiting
NCT05723991 2023-02-13
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
Tongji Hospital
Phase 4 Unknown
NCT05701332 2023-01-27
Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume
Assiut University
Phase 4 Unknown
NCT05035147 2021-09-21
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Recruiting
NCT04999878 2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4 Unknown
NCT02812992 2021-08-10
GrantPax
AIO-Studien-gGmbH
Phase 4 Completed
NCT04040491 2020-05-12
PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT03071822 2018-06-11
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas
The University of Hong Kong
Phase 4 Unknown
NCT03401827 2018-02-12
The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer
Seoul National University Hospital
Phase 4 Unknown
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated
NCT02316327 2016-10-05
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Completed
NCT01501136 2015-07-17
CTTNKTL-I/II
Zhengzhou University
Phase 4 Unknown
NCT01336192 2011-04-15
MAGICAL
Tongji University
Phase 4 Unknown